SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Anuh Pharma - Quaterly Results

09 Aug 2024 Evaluate
The sales declined to Rs. 1379.08 millions for the June 2024 quarter as compared to Rs. 1614.81 millions during the corresponding quarter last year.A slender decline of -19.09% was recorded to Rs. 95.08  millions from Rs. 117.52 millions in the corresponding previous quarter.The Operating Profit of the company witnessed a decrease to 142.87 millions from 174.44 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1379.08 1614.81 -14.60 1379.08 1614.81 -14.60 6470.04 5274.86 22.66
Other Income 37.19 34.70 7.18 37.19 34.70 7.18 120.98 61.15 97.84
PBIDT 142.87 174.44 -18.10 142.87 174.44 -18.10 872.47 573.90 52.02
Interest 1.42 0.22 545.45 1.42 0.22 545.45 3.54 2.18 62.39
PBDT 141.45 174.22 -18.81 141.45 174.22 -18.81 868.93 571.72 51.99
Depreciation 18.80 20.09 -6.42 18.80 20.09 -6.42 85.84 97.00 -11.51
PBT 122.65 154.13 -20.42 122.65 154.13 -20.42 783.09 474.72 64.96
TAX 27.57 36.61 -24.69 27.57 36.61 -24.69 182.52 112.91 61.65
Deferred Tax 0.37 0.01 3600.00 0.37 0.01 3600.00 3.59 -8.29 -143.31
PAT 95.08 117.52 -19.09 95.08 117.52 -19.09 600.57 361.81 65.99
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 10.36 10.80 -4.10 10.36 10.80 -4.10 13.48 10.88 23.94

Anuh Pharma Share Price

82.80 0.08 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×